Skip to main content
Premium Trial:

Request an Annual Quote

DxTerity, Texas Department of State Health Services Coronavirus Molecular Tests Get FDA EUAs

NEW YORK — The US Food and Drug Administration on Friday granted separate Emergency Use Authorizations for PCR-based SARS-CoV-2 tests developed by DxTerity Diagnostics and the Texas Department of State Health Services (DSHS).

The DxTerity SARS-CoV-2 RT-PCR Test is designed to detect the virus' N, S, and ORF1ab genes in saliva specimens. RNA extraction is performed using Thermo Fisher Scientific's Applied Biosystems MagMax 96 Magnetic Particle Processor and the test runs on the Applied Biosystems ViiA 7 Real-Time PCR System.

DxTerity's test, which uses primers and probes developed and validated under the Emergency Use Authorization for Thermo Fisher's Applied Biosystems TaqPath COVID-19 Combo Kit, can be used by any lab CLIA-certified to perform high-complexity testing.

The Texas DSHS SARS-CoV-2 Assay is designed to detect the N and ORF1ab genes of the virus in nasopharyngeal, oropharyngeal, anterior nasal, and midturbinate nasal swabs, as well as nasal aspirates, nasal washes, and bronchoalveolar lavage fluid specimens.

The test uses PerkinElmer's Chemagic 360 instrument for nucleic acid purification and runs on Thermo Fisher's Applied Biosystems 7500 Fast Dx Real-Time PCR System. PerkinElmer's Janus G3 Automated Workstation may also be used for sample preparation.

The Texas DSHS test may be used by any lab CLIA-certified to perform high-complexity testing, the FDA said.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.